Literature DB >> 8886884

Malignant melanoma arising in mature ovarian cystic teratoma (dermoid cyst). Report of two cases and literature analysis.

G L Davis1.   

Abstract

Malignant melanoma may originate from melanocytes in ovarian cystic teratomas (dermoid cysts). Two cases are reported here and an additional 17 cases are found in a literature review covering 1903-1995. The review also found cases of benign and malignant melanotic ovarian lesion unassociated with dermoid cyst, including four melanomas, three cases of benign nevus, five cases of benign melanosis, and four cases of benign and malignant retinal anlage tumors. The extremely rare primary ovarian melanoma may be differentiated from the more common melanoma metastatic to the ovaries by its unilaterality, the presence of junctional change, and a detailed history and physical examination to exclude another primary site. Overall, 50% of patients with Stage I dermoid-associated melanoma were alive at 2 years compared with 89% of patients with Stage I dermoid-associated squamous carcinoma at 5 years. In the last 10 years, however, with the application o aggressive chemotherapy, survival has improved.

Entities:  

Mesh:

Year:  1996        PMID: 8886884     DOI: 10.1097/00004347-199610000-00009

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  2 in total

1.  Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19-9: a case report and review of literature.

Authors:  Won Ku Choi; Dong Hyun Lee; Dong Hyu Cho; Kyu Yun Jang; Kyoung Min Kim
Journal:  BMC Womens Health       Date:  2019-11-27       Impact factor: 2.809

2.  Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case Report.

Authors:  Kohei Nakamura; Eriko Aimono; Reika Takamatsu; Shigeki Tanishima; Tomonari Tohyama; Katsutoshi Sasano; Hiroshi Sakuma; Hiroshi Nishihara
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.